Effect of superparamagnetic nanoparticles coated with various electric charges on α-synuclein and β-amyloid proteins fibrillation process

References

• FinkALProtein aggregation: folding aggregates, inclusion bodies and amyloidFold Des199831R9R239502314
   PubMedGoogle Scholar
• MannoMMauroMCraparoEFPodestAKinetics of different processes in human insulin amyloid formationJ Mol Biol2007366125827417157312
   PubMed Web of Science ®Google Scholar
• ShererTBKimJHBetarbetRGreenamyreJTSubcutaneous rote-none exposure causes highly selective dopaminergic degeneration and α-synuclein aggregationExperimental Neurology2003179191612504863
   PubMed Web of Science ®Google Scholar
• ClearyJPWalshDMHofmeisterJJNatural oligomers of the amyloid-beta protein specifically disrupt cognitive functionNat Neurosci200581798415608634
   PubMed Web of Science ®Google Scholar
• WalshDMHartleyDMKusumotoYAmyloid beta-protein fibrillogenesis. Structure and biological activity of protofibrillar intermediatesJ Biol Chem199927436259452595210464339
   PubMed Web of Science ®Google Scholar
• MahmoudiMMilaniASStroevePSynthesis, surface architecture and biological response of superparamagnetic iron oxide nanoparticles for application in drug delivery: a reviewInt J Biomed Nanosci Nanotechnol201012/3/4164201
   Google Scholar
• MahmoudiMShokrgozarMAMultifunctional stable fluorescent magnetic nanoparticlesChem Commun2012483339573959
   PubMed Web of Science ®Google Scholar
• LiaoYHChangYJYoshiikeYChangYCChenYRNegatively charged gold nanoparticles inhibit Alzheimer’s amyloid-β fibrillization, induce fibril dissociation, and mitigate neurotoxicitySmall20128233631363922915547
   PubMed Web of Science ®Google Scholar
• GlatMSkaatHMenkes-CaspiNMargelSSternEAAge-dependent effects of microglial inhibition in vivo on Alzheimer’s disease neuropathology using bioactive-conjugated iron oxide nanoparticlesJ Nanobiotechnology20131113224059692
   PubMedGoogle Scholar
• MahmoudiMSantSWangBLaurentSSenTSuperparamagnetic iron oxide nanoparticles (SPIONs): development, surface modification and applications in chemotherapyAdv Drug Deliv Rev2011631–2244620685224
   PubMed Web of Science ®Google Scholar
• TauranYBrioudeAColemanAWRhimiMKimBMolecular recognition by gold, silver and copper nanoparticlesWorld J Biol Chem201343356323977421
   PubMedGoogle Scholar
• BreydoLWuJWUverskyVNα-Synuclein misfolding and Parkinson’s diseaseBiochim Biophys Acta20121822226128522024360
   PubMed Web of Science ®Google Scholar
• KuntworbeNAl-KassasRDesign and in vitro haemolytic evaluation of cryptolepine hydrochloride-loaded gelatine nanoparticles as a novel approach for the treatment of malariaAAPS PharmSciTech201213256858122477022
   PubMed Web of Science ®Google Scholar
• MahmoudiMSimchiAImaniMRecent advances in surface engineering of superparamagnetic iron oxide nanoparticles for biomedical applicationsJ Iran Chem Soc20107S2S1S27
   Google Scholar
• ShangWNufferJHDordickJSSiegelRWUnfolding of ribonuclease A on silica nanoparticle surfacesNano Letters2007771991199517559285
   PubMedGoogle Scholar
• KhlebtsovNDykmanLBiodistribution and toxicity of engineered gold nanoparticles: a review of in vitro and in vivo studiesChem Soc Rev20114031647167121082078
   PubMed Web of Science ®Google Scholar
• Ai TranHNSousaFModaFA novel class of potential prion drugs: preliminary in vitro and in vivo data for multilayer coated gold nanoparticlesNanoscale20102122724273220944860
   PubMed Web of Science ®Google Scholar
• CiminiAD’AngeloBDasSAntibody-conjugated PEGylated cerium oxide nanoparticles for specific targeting of Aβ aggregates modulate neuronal survival pathwaysActa Biomater2012862056206722343002
   PubMed Web of Science ®Google Scholar
• YangCCYangSYChiehJJBiofunctionalized magnetic nanoparticles for specifically detecting biomarkers of Alzheimer’s disease in vitroACS Chem Neurosci20112950050522860173
   PubMed Web of Science ®Google Scholar
• SillerudLOSolbergNOChamberlainRSPION-enhanced magnetic resonance imaging of Alzheimer’s disease plaques in AβPP/PS-1 transgenic mouse brainJ Alzheimers Dis201334234936523229079
   PubMed Web of Science ®Google Scholar
• SigalitGShlomoMinventors; Bar-Ilan University, assigneeNucleation and growth of magnetic metaloxide nanoparticles and its useIsrael patentWO 1999062079A119991202
   Google Scholar
• LiuGMenPPerryGSmithMANanoparticle and iron chelators as a potential novel Alzheimer therapyFree radicals and antioxidant protocolsNew York, NYHumana Press2010123144
   Google Scholar
• Cabaleiro-LagoCQuinlan-PluckFLynchIInhibition of amyloid beta protein fibrillation by polymeric nanoparticlesJ Am Chem Soc200813046154371544318954050
   PubMed Web of Science ®Google Scholar
• SahniJKDogguiSAliJBabootaSDaoLRamassamyCNeurotherapeutic applications of nanoparticles in Alzheimer’s diseaseJ Control Release2011152220823121134407
   PubMed Web of Science ®Google Scholar
• SkaatHShafirGMargelSAcceleration and inhibition of amyloid-β fibril formation by peptide-conjugated fluorescent-maghemite nanoparticlesJ Nanopart Res201113835213534
   Google Scholar
• YooSIYangMBrenderJRInhibition of amyloid peptide fibrillation by inorganic nanoparticles: functional similarities with proteinsAngew Chem Int Ed Engl201150225110511521495130
   PubMed Web of Science ®Google Scholar
• MaroteauxLCampanelliJTSchellerRHSynuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminalJ Neurosci198888280428153411354
   PubMed Web of Science ®Google Scholar
• HarperJDLieberCMLansburyPTJrAtomic force microscopic imaging of seeded fibril formation and fibril branching by the Alzheimer’s disease amyloid-β proteinChemistry & biology19974129519599427660
   PubMedGoogle Scholar
• KooEHLansburyPTKellyJWAmyloid diseases: abnormal protein aggregation in neurodegenerationProceedings of the National Academy of Sciences1999961899899990
   PubMed Web of Science ®Google Scholar